This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Corticosteroid toxicity (systemic)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Cushing's syndrome refers to the set of clinical features resulting from persistently and inappropriately elevated levels of glucocorticoid. Usually the condition is iatrogenic.

  • estimated incidence of Cushing syndrome due to endogenous overproduction of cortisol ranges from 2 to 8 per million people annually (1)

Spontaneous Cushing's syndrome is rare, more common in females, and in about two-thirds of cases, due to Cushing's disease, that is due to pituitary-dependent adrenal hyperplasia

  • can be broadly divided into adrenocorticotropic hormone (ACTH)-dependent (approximately 80%; Cushing's disease (CD), ectopic ACTH secreting tumors, corticotropin-releasing hormone (CRH)-secreting tumors) and ACTH-independent (20%; adrenal tumor, carcinoma, and macronodular hyperplasia (AIMAH)) (2)
    • CD refers to a rare disorder caused by pituitary corticotroph tumors and represents the most common cause (nearly 70% in adults) of endogenous CS

Identification of the cause of the condition is essential to effective management.

Evaluation of patients with possible Cushing syndrome begins with ruling out exogenous steroid use

  • screening for elevated cortisol is performed with a 24-hour urinary free cortisol test or late-night salivary cortisol test or by evaluating whether cortisol is suppressed the morning after an evening dexamethasone dose
  • plasma corticotropin levels can help distinguish between adrenal causes of hypercortisolism (suppressed corticotropin) and corticotropin-dependent forms of hypercortisolism (midnormal to elevated corticotropin levels)
  • pituitary magnetic resonance imaging, bilateral inferior petrosal sinus sampling, and adrenal or whole-body imaging can help identify tumor sources of hypercortisolism

Management of Cushing syndrome

  • surgical intervention to remove the source of excess endogenous cortisol production followed by medication that includes adrenal steroidogenesis inhibitors, pituitary-targeted drugs, or glucocorticoid receptor blockers.
  • radiation therapy and bilateral adrenalectomy may be appropriate if patient does not respond to surgery and medical treatment (1)

Reference:

  • Reincke M, Fleseriu M. Cushing Syndrome: A Review. JAMA. 2023;330(2):170–181. doi:10.1001/jama.2023.11305
  • Nishioka H, Yamada S. Cushing's Disease. J Clin Med. 2019 Nov 12;8(11):1951. doi: 10.3390/jcm8111951. PMID: 31726770; PMCID: PMC6912360.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.